Suchergebnisse - "Li, Shance"

PubPharm (16)

1

T cells engineered with full-length NKG2D linked to signaling domains of 4-1BB and CD3ζ show enhanced antitumor activity

enthalten in: Immunology and cell biology | 2023

von Teng, X. | Rong, Z. | Li, S. | +2

2

TCR extracellular domain genetically linked to CD28, 2B4/41BB and DAP10/CD3ζ -engineered NK cells mediates antitumor effects

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Li, S. | Zhang, C. | Shen, L. | +4

3

Autophagic flux restoration enhances the antitumor efficacy of tumor infiltrating lymphocytes

enthalten in: Journal for immunotherapy of cancer | 2022

von Zhang, C. | Sun, Y. | Li, S. | +5

4

TCR extracellular domain genetically linked to CD28, 2B4/41BB and DAP10/CD3ζ -engineered NK cells mediates antitumor effects

enthalten in: Cancer immunology immunotherapy | 2022

von Li, S. | Zhang, C. | Shen, L. | +4

5

TCR extracellular domain genetically linked to CD28, 2B4/41BB and DAP10/CD3ζ -engineered NK cells mediates antitumor effects

enthalten in: Cancer immunology immunotherapy | 2022

von Li, S. | Zhang, C. | Shen, L. | +4

6

Metabolic reprogramming by ex vivo glutamine inhibition endows CAR-T cells with less-differentiated phenotype and persistent antitumor activity

enthalten in: Cancer letters | 2022

von Shen, L. | Xiao, Y. | Zhang, C. | +6

7

TCR extracellular domain genetically linked to CD28, 2B4/41BB and DAP10/CD3ζ-engineered NK cells mediates antitumor effects

enthalten in: ResearchSquare.com | 2022

von Li, S. | Zhang, C. | Shen, L. | +3

8

Autophagic flux restoration of senescent T cells improves antitumor activity of TCR-engineered T cells

enthalten in: Clinical & translational immunology | 2022

von Zhang, C. | Sun, Y. | Li, S. | +5

9

Autophagic flux restoration of senescent T cells improves antitumor activity of TCR‐engineered T cells

enthalten in: Clinical & Translational Immunology | 2022

von Zhang, C. | Sun, Y. | Li, S. | +5

10

Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies

enthalten in: Journal for immunotherapy of cancer | 2021

von Zhang, C. | Tan, Q. | Li, S. | +5